When resistance to glycopeptides is detected, alternative antibiotics such as linezolid, daptomycin, and tigecycline may be used. These alternatives often come with their own set of challenges, including higher costs and potential side effects. The choice of alternative therapy depends on the susceptibility profile of the bacteria and the clinical condition of the patient.
